Paul-Ehrlich-Institut Highlights Vaccines and Antibodies in Fight Against Antimicrobial Resistance
For World AMR Awareness Week, the German regulator outlines how vaccines curb antibiotic use and discusses EMA scientific advice on trials of vaccines and antibodies against resistant bacteria.
The Paul-Ehrlich-Institut (PEI), Germany's federal institute for vaccines and biomedical medicines, has published an awareness piece for World AMR Awareness Week, which runs from 18 to 24 November 2026. It sets out why vaccination matters in tackling antimicrobial resistance and presents recent research on clinical trials of vaccines and monoclonal antibodies aimed at resistant bacteria.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
Official source: Paul-Ehrlich-Institut ↗
Article written by VigiEye from the official source (Paul-Ehrlich-Institut). AI-assisted; check the source before acting.